BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3114414)

  • 1. The single-dose bioavailability of different lithium carbonate products.
    Tsang HY; Chen CC; Wen JK
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):543-8. PubMed ID: 3114414
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
    Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
    J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations.
    Arancibia A; Corvalan F; Mella F; Concha L
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):240-5. PubMed ID: 3089949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antacid on the bioavailabiity of lithium carbonate.
    Goode DL; Newton DW; Ueda CT; Wilson JE; Wulf BG; Kafonek D
    Clin Pharm; 1984; 3(3):284-7. PubMed ID: 6428800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose bioavailability of two extended-release lithium carbonate products.
    Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
    Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of lithium preparations in patients.
    Johnson GF; Hunt GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):63-70. PubMed ID: 6427848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and safety of a priori lithium loading.
    Kook KA; Stimmel GL; Wilkins JN; Spangher GG
    J Clin Psychiatry; 1985 Feb; 46(2):49-51. PubMed ID: 3918024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of lithium carbonate: single versus multiple daily dosing.
    Bone S; Roose SP; Dunner DL; Fieve RR
    J Clin Psychopharmacol; 1981 Nov; 1(6):390-1. PubMed ID: 6801097
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a slow-release lithium carbonate formulation.
    Cooper TB; Simpson GM; Lee JH; Bergner PE
    Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of the therapeutic dose of lithium carbonate--Polfa on the basis of 24-hour load].
    Rybakowski J
    Pol Tyg Lek; 1984 Mar; 39(12):407-9. PubMed ID: 6433336
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability of lithium carbonate: in vivo comparison of two products.
    Meinhold JM; Spunt AL; Trirath C
    J Clin Pharmacol; 1979; 19(11-12):701-3. PubMed ID: 536466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
    Panteleeva GP; Mikhaĭlova NM; Beliaev BS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two lithium carbonate formulations.
    Foster TS; Crass RE; Bustrack JA; Smith RB; Munson JW
    Am J Hosp Pharm; 1980 Nov; 37(11):1528-31. PubMed ID: 7211858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption & urinary & salivary excretion of lithium after oral administration.
    Doshi BS; Rout SJ; Kulkarni RD
    Indian J Med Res; 1983 Nov; 78():708-12. PubMed ID: 6423533
    [No Abstract]   [Full Text] [Related]  

  • 17. Absorption of lithium following administration of slow-release and conventional preparations.
    Tyrer S; Hullin RP; Birch NJ; Goodwin JC
    Psychol Med; 1976 Feb; 6(1):51-8. PubMed ID: 935297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of dosage schedules for delayed-action lithium carbonate].
    Balon R; Kabesh Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of lithium in the dog.
    Rosenthal RC; Koritz GD; Davis LE
    J Vet Pharmacol Ther; 1986 Mar; 9(1):81-7. PubMed ID: 3009841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
    Caldwell HC; Westlake WJ; Connor SM; Flanagan T
    J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.